Literature DB >> 17372

Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.

S G Hastings, R D Smith, R M Corey, A D Essenburg, C E Pettway, D K Tessman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17372

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


× No keyword cloud information.
  4 in total

1.  Myocardial functional preservation during ischemia: influence of beta blocking agents.

Authors:  P M Toleikis; C W Tomlinson
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

2.  Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

Review 3.  Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.

Authors:  W H Frishman; R J Goldberg; P Benfield
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

4.  Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjects.

Authors:  A Selen; A W Kinkel; A C Darke; D S Greene; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.